Regentis Biomaterials (RGNT) Equity Average (2025)
Regentis Biomaterials (RGNT) reported Equity Average of -$18.2 million for Q4 2025.
Regentis Biomaterials (RGNT) Equity Average (2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 1 years of Equity Average data on file, last reported at -$18.2 million in Q4 2025.
- Equity Average for Q4 2025 came in at -$18.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$18.2 million (changed N/A YoY), and the FY2025 annual result was -$18.2 million, up 58.21% from the prior year.
- Equity Average steadied at -$18.2 million in Q4 2025 per RGNT's latest filing.
- Over five years, Equity Average peaked at -$18.2 million in Q4 2025 and troughed at -$18.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.71 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 20.42 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 11.00 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 6.41 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 3.08 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 5.01 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 8.30 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 6.07 Bn |
| 10 | Regentis Biomaterials | 3.72 Mn | -3.66 Mn | - | -18.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.18 Mn |